Real-world data of first-line treatment with pembrolizumab for non-small cell lung cancer with high PD-L1 expression (HOT/NJLCG2001)

被引：0

作者：

Yokouchi, H. ^{[1
]}

Mizugaki, H. ^{[2
]}

Ikezawa, Y. ^{[3
]}

Morita, R. ^{[4
]}

Tateishi, K. ^{[5
]}

Yokoo, K. ^{[6
]}

Sumi, T. ^{[7
]}

Kikuchi, H. ^{[8
]}

Nakamura, A. ^{[9
]}

Kobayashi, M. ^{[10
]}

Aso, M. ^{[11
]}

Tsukita, Y. ^{[12
]}

Yoshiike, F. ^{[13
]}

Furuta, M. ^{[14
]}

Tanaka, H. ^{[15
]}

Sekikawa, M. ^{[16
]}

Hachiya, T. ^{[17
]}

Nakamura, K. ^{[18
]}

Kitamura, Y. ^{[19
]}

机构：

[1] Hokkaido Canc Ctr, Dept Resp Med, Fukushima, Japan

[2] Japanese Fdn Canc Res, Canc Immunotherapy Dev, Adv Med Dev Ctr, Canc Inst Hosp, Koto Ku, Tokyo, Japan

[3] Oji Gen Hosp, Dept Resp Med, Tomakomai, Japan

[4] Akita Kousei Med Ctr, Thorac Oncol, Akita, Nishibukuro, Japan

[5] Shinshu Univ, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano, Japan

[6] Teine Keijinkai Hosp, Dept Resp Med, Sapporo, Hokkaido, Japan

[7] Hakodate Goryoukaku Hosp, Dept Resp Med, Hakodate, Hokkaido, Japan

[8] JA Hokkaido Kouseiren Obihiro Kosei Gen Hosp, Dept Resp Med, Obihiro, Hokkaido, Japan

[9] Sendai Kousei Hosp, Dept Resp Med, Sendai, Miyagi, Japan

[10] Miyagi Canc Ctr, Resp Med, Natori, Miyagi, Japan

[11] Yamagata Prefectural Cent Hosp, Pulm Med, Yamagata, Japan

[12] Tohoku Univ, Dept Resp Med, Sendai, Miyagi, Japan

[13] Nagano Municipal Hosp, Dept Resp Med, Nagano, Japan

[14] Hokkaido Univ Hosp, Dept Resp Med, Sapporo, Hokkaido, Japan

[15] Hirosaki Univ, Dept Resp Med, Hirosaki, Aomori, Japan

[16] Steel Mem Muroran Hosp, Dept Resp Med, Muroran, Hokkaido, Japan

[17] Suwa Red Cross Hosp, Dept Resp Med, Suwa, Japan

[18] Natl Hosp Org Asahikawa Med Ctr, Dept Resp Med, Asahikawa, Hokkaido, Japan

[19] Kushiro City Gen Hosp, Dept Resp Med, Kushiro, Japan

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.10.373

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

335P

引用

页码：S1574 / S1574

页数：1